Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab

A 67-year-old man with primary lung adenocarcinoma was hospitalized due to massive bilateral pleural effusion and pericardial effusion after 94 cycles of nivolumab therapy. We were unable to identify the cause of these effusions using blood tests, cytology tests, or bacterial culture of pleural effu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawada, Ryo, Matsui, Yohei, Uchino, Junji, Okura, Naoko, Morimoto, Yoshie, Iwasaku, Masahiro, Kaneko, Yoshiko, Yamada, Tadaaki, Takayama, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666223/
https://www.ncbi.nlm.nih.gov/pubmed/34092733
http://dx.doi.org/10.2169/internalmedicine.7219-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666223/
https://www.ncbi.nlm.nih.gov/pubmed/34092733
http://dx.doi.org/10.2169/internalmedicine.7219-21

Ejemplares similares